|
PLEKHG4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.223000E-03 |
| Normal-vs-Stage3 |
1.62492241884138E-12 |
| Normal-vs-Stage4 |
1.47129974870097E-10 |
| Stage1-vs-Stage2 |
2.807600E-02 |
| Stage1-vs-Stage3 |
4.017600E-01 |
| Stage1-vs-Stage4 |
8.642000E-04 |
| Stage2-vs-Stage3 |
1.105570E-02 |
| Stage2-vs-Stage4 |
3.53480000000461E-05 |
| Stage3-vs-Stage4 |
5.137900E-03 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
4.42480000000245E-05 |
| Normal-vs-Asian |
1.10840003841872E-10 |
| Caucasian-vs-AfricanAmerican |
1.025570E-01 |
| Caucasian-vs-Asian |
3.835000E-01 |
| AfricanAmerican-vs-Asian |
4.490000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62492241884138E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
1.533360E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(61-80Yrs) |
1.43220002524203E-09 |
| Normal-vs-Age(81-100Yrs) |
1.696270E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.706200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.719600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.938200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.551400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.648200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.534200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.297000E-01 |
| Classical-VS-Follicular |
3.05711012060783E-12 |
| Classical-VS-Other |
3.440000E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
1.34139999996563E-06 |
| Tall-VS-Other |
1.827760E-01 |
| Tall-VS-Normal |
7.71279706768269E-11 |
| Follicular-VS-Other |
1.280810E-01 |
| Follicular-VS-Normal |
2.871700E-02 |
| Other-VS-Normal |
8.184200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62436730732907E-12 |
| Normal-vs-N1 |
7.21329995734266E-10 |
| N0-vs-N1 |
1.926240E-02 |
|
|
